Sativa Wellness Group qualifies for new Apex segment of the AQSE Growth Market

Sativa Wellness Group plc (AQSE:SWEL) has noted the announcement by the Aquis Stock Exchange PLC, that the two new segments of the market have come into force. Please see Aquis Stock Exchange link for the full announcement.

Sativa Wellness has been notified by AQSE that it qualifies for the “Apex” segment of the AQSE Growth Market. In order to be eligible for admission to Apex, Sativa has succeeded in meeting, amongst other things, the following eligibility criteria:

·   A minimum market capitalisation of £10 million

·   At least 25% shares in public hands

·   At least 2 market makers

·   A minimum 2 years’ trading history

·   Adopted a recognised governance code

In meeting the above criteria, the Company expects that there will be more retail and institutional interest, leading to higher trading volumes, and an enhanced ability to use its APEX segment public market status to raise money.

Henry Lees-Buckley, CEO of the Sativa Wellness Group Inc. stated “the status of the Apex segment is clearly designed for more established companies that have experienced boards and corporate governance standards. We welcome this segmentation from the Aquis Stock Exchange, and believe that the Apex segment is better placed to support our growth ambitions”.    

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
DirectorsTalk

More articles like this

Sativa Wellness Group Management Share Compensation Arrangements

Sativa Wellness Group plc (AQSE:SWEL / CNSX:SWEL) today announced certain management share compensation arrangements and amendments that have been approved by the Board of Directors with a view to both incentivising and aligning management and shareholder interests. Firstly, following

Use of Cannabidiol for the treatment of Anxiety

A macro-analysis of 49 different research papers (focusing primarily on animal studies) on the effects of CBD regarding multiple anxiety or stress-oriented disorders, such as Post-Traumatic Stress Disorder, Generalised Anxiety Disorder, and Social Anxiety Disorder to

The “Runner’s High” and Endocannabinoids

A runner’s high is a sense of well-being some people experience after prolonged exercise. For decades, it was hypothesized that exercise-induced endorphin release is solely responsible for a runner’s high, but recent evidence has suggested that

CBD bioavailability and why it matters

Wealth, friends, and even spouses, if lost, can be regained or acquired again somehow. But the body, once gone, will never come back- no matter how hard we try to revive the life that’s lost. Our

Finding relief from aches and pains

Everyone at some point of their life will experience some aches and pain, and it could be because of a whole range of different reasons. For some of us, that would be a bit of joint

CBD and mental health: A systematic analysis

There is a lot of research about the positive effects of CBD and Mental Health.  This report is a systematic analysis of a multitude of different research papers and conducted trials with regards to CBD’s impact

General benefits of CBD

CBD has been reported to help people in a number of ways. From pain relief, memory, and sleep to name a few, there’s a chance that we could all benefit from CBD in one way or

CBD and Diabetes: How can it help?

Close to 4.9 million people in the UK have been diagnosed with diabetes, with a further 850,000 people suspected to be living with undiagnosed type 2 diabetes. To add on to this, 13.6 million people in

The effects of cannabidiol on cerebral blood flow

The primary aim of this research paper was to investigate how CBD influences cerebral blood flow (CBF) in regions involved in memory processing. It was conducted under a randomised, crossover, double-blind design in which 15 healthy

Sativa Wellness Group Report record Q3 revenues (Interview)

Sativa Wellness Group Inc. (AQSE:SWEL / CNSX:SWEL) CEO Mark Howells joins DirectorsTalk Interviews to discuss a record quarterly profit in Q3 2021. Mark talks us through the numbers, explains how sustainable the performance is and plans